Wikidata

(Q40465372)

English

Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).

scientific article published on January 2005

In more languages

Statements

title
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15671558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40465372&oldid=1846261762"